max original heaven s gate tonight at 10 on cnn. this is gps. the global public square. welcome to all of you in the united states and around the world. i m fareed zakaria coming to you live from new york. today on the program, the indictment of donald j. trump i ll give you my take on this historic moment and more than a year after putin s invasion of ukraine battle for bomb rages on what are the lessons we can draw from putin s protracted war and how can ukrainians win this fight? i ll ask the military strategist who commanded many high profile missions throughout his career, including the raid on osama bin laden. retired navy four star admiral william mcraven. finally very special conversation with one of the world s greatest film directors. sit down with james cameron to discuss the role of technology and movie making. passionate work to protect the planet. and what he thinks explains the stunning global success of his movies. but first here s my take. the news of dona
my take on this historic moment. and more than a year after putin s invasion of ukraine. the battle for bomber rages on. what are the lessons we can draw from putin s protracted war and how can ukrainians win this fight? i ll ask the military strategist who commanded many high profile missions throughout his career, including the raid on osama bin laden. retired navy four star admiral william mcraven. finally very special conversation with one of the world s greatest film directors. sit down with james cameron to discuss the role of technology and movie making. passionate work to protect the planet and what he thinks explains the stunning global success of his movies. but first here s my take. the news of donald trump s indictment has left me feeling torn. on the one hand, trump is a walking advertisement for rich privilege . for decades, he has flouted rules, norms and even laws as he climbed his way to the top, brazenly convinced that the usual standards didn t apply to him
After years of disappointing ALS clinical trial results, this year's Sheila Essey Award recipient for significant contributions in ALS research is shifting to prevention.
The lecanemab open-label extension trial for AD showed no new safety signals, but the placebo roll-over group failed to show the gains seen in the experimental arm.